Ascletis Secures FDA IND Clearance for Phase II Di...
Category : Product Related Updates 5 January 2026Ascletis Pharma has received FDA IND clearance to begin a Phase II study of ASC30 in type 2 diabetes...
Product Related Updates
TempraMed Secures New South Korea Patent for VIVI...
Category : Product Related Updates 17 December 2025TempraMed Technologies has strengthened its global intellectual property portfolio with a newly gran...
Novo’s oral semaglutide edges out CagriSema, Lilly...
Category : Product Related Updates 16 December 2025"As both Novo Nordisk and Eli Lilly race to develop their long-anticipated oral GLP-1 obesity m...
Oral Semaglutide Shows Promising Weight-Loss and H...
Category : Product Related Updates 12 December 2025Obesity Week 2025 delivered a major update in obesity care: new clinical findings show that a daily...
AskBio’s Gene Therapy Programs Earn Japan’s SAKIGA...
Category : Product Related Updates 11 December 2025Japan has taken a major step toward accelerating access to next-generation gene therapies. AskBio, a...
Latest Newsletter Post
-
MetaVia’s DA-1726 Delivers Rapid, S..
6 January 2026
-
Delova Reports Positive Phase 3 Res..
6 January 2026
-
GenEditBio Secures US FDA IND Clear..
6 January 2026
-
AstraZeneca’s Baxdrostat Shows Stro..
6 January 2026
-
Ascletis Secures FDA IND Clearance..
5 January 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com